The Liver Meeting 2019-Assessment of Abnormal Liver Biochemistries

Video Transcription

Video Summary

Dr. Kuo gave a detailed presentation on assessing abnormal liver biochemistries, emphasizing the importance of understanding liver tests versus liver function tests. Commonly ordered tests such as ALT, AST, ALKFOS, and bilirubin were discussed as markers of liver injury, not function. Liver function tests like albumin and prothrombin time were also mentioned. The evolving normal ranges of liver tests, especially ALT levels, were highlighted in relation to liver-related mortality rates. The impact of lifestyle factors like exercise on liver tests was addressed, along with the need to consider external factors such as medications and supplements. Specific conditions like non-alcoholic fatty liver disease, hepatitis C, and hemochromatosis were explained, with guidance on interpreting and evaluating liver test abnormalities. Advice on patient follow-up and interventions based on test results was provided, along with insights into the impact of substances like CBD, THC, and cannabis on liver function. Terminology was discussed, recommending replacing "liver function tests" with "liver tests" when communicating with patients to avoid misunderstanding and anxiety.

Asset Caption

Presenter: Paul Yien Kwo

Keywords

liver biochemistries

liver tests

ALT

AST

bilirubin

albumin

prothrombin time